As a medical development company, Ventus Medical is committed to creating high-quality, effective, products which offer new and unique ways to benefit public health and pharmaceutical innovation.
We’re developing the next generation of safer nicotine products
Smoking is a risk to public health, and we’re currently working on products which shake up the industry and provide a safer way for smokers to consume nicotine and ultimately quit smoking.
Our first product, ENHALE, has been CE marked as a medical device in the European Union under the Medical Devices Directive and is currently undergoing regulatory approval as a form of Nicotine Replacement Therapy.
Our extensive research into nicotine delivery, stability and aerosol science has allowed us to develop innovative solutions for a safe and effective way to deliver nicotine.
We’re focused on public health
Public health is at the forefront of our work as we develop new tools which improve the quality of life of the population and reduce morbidity and mortality.
Quality is one of our core values, and all of our devices undergo rigorous quality testing to ensure that they are safe and effective. The quality of the work we do is certified by the British Standards Institution (BSI) to the international standards ISO9001 and ISO13485. These standards guide our working practices and ensure that our development and innovations are guided by the best possible working practices.
Our varied team and agile development strategy promote innovation
With a varied team of specialists in different areas of science and technology, we bring together the expertise needed to create, develop and protect the most innovative products with the goal of protecting public health.
We take a uniquely agile approach to our work, fostering a creative environment built on quality to ensure that we are able to deliver groundbreaking products and technologies.